Actelion
26 results

New cancer drugs help Johnson & Johnson edges past profit estimates
- Health & Pharma
- October 16, 2018, 16:45
Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its c(...)

J&J’s profit beat estimates thanks to new cancer drugs
- Health & Pharma
- October 17, 2017, 16:41
Pharma giant Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast, driven by strong demand for its(...)

New cancer drugs see Johnson & Johnson lift 2017 profit forecast
- Health & Pharma
- July 18, 2017, 15:55
Johnson & Johnson raised its full-year profit forecast and reported better-than-expected quarterly earnings on Tuesday, helped by strong demand f(...)

M&A boost helps European shares stay at one-year high
- Markets
- January 26, 2017, 19:59
European shares held around one-year highs on Thursday, supported by mergers and acquisitions-related optimism, with Johnson & Johnson’s $30 billi(...)

Johnson & Johnson agrees $30bn deal to buy Actelion
- Health & Pharma
- January 26, 2017, 17:27
Johnson and Johnson (JandJ) has agreed to buy Actelion for $30 billion (€28.1bn), clinching one of its largest ever deals to become a leader in medici(...)

J&J discussing breaking up Actelion in acquisition
- Health & Pharma
- December 29, 2016, 16:28
Johnson & Johnson is negotiating a deal to acquire Swiss biotechnology company Actelion Ltd that would separate Actelion’s commercialised portfoli(...)

European stocks drift lower as end-of-year rally fizzles out
- Markets
- December 22, 2016, 19:07
European stocks inched lower amid thin trading, with investors signalling reluctance to extend a rally as the last full trading week of 2016 unfolded.(...)

Twist in Actelion tale as ‘strategic’ talks restart with J&J
- Health & Pharma
- December 22, 2016, 09:10
In a surprise twist to one of 2016’s biggest potential health deals, Actelion and US drug giant Johnson and Johnson are back at the negotiating table (...)

Actelion shares gain on report of progress in Sanofi talks
- Health & Pharma
- December 21, 2016, 09:37
Swiss biotech group Actelion’s shares rose by more than 3 per cent on Wednesday following a report that talks with Sanofi are making progress, increas(...)

European stocks climb to 11-month high
- Markets
- December 16, 2016, 18:13
European stocks climbed to an 11-month high on merger and acquisition speculation on Friday, while the dollar’s rally paused as investors adjusted the(...)